Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AbbVie Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (148)
Cancellation by sponsor (87)
Prescription medicine registration (25)
Australian public assessment report (AusPar) (22)
Designation or determination (7)
Prescription medicine evaluation (2)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2025 (27)
2024 (26)
2023 (26)
2022 (14)
2021 (14)
2020 (20)
2019 (24)
2018 (14)
2017 (29)
2016 (5)
2015 (19)
2014 (28)
2013 (4)
2012 (4)
2011 (4)
2010 (5)
2009 (4)
2008 (3)
2007 (1)
2006 (4)
2005 (4)
2002 (2)
2001 (1)
1999 (1)
1998 (1)
1997 (1)
1996 (1)
1994 (2)
1991 (5)

Search

Sponsor content

293 result(s) found, displaying 161 to 170

VENCLEXTA venetoclax 100 mg film-coated tablet blister pack (267442)

5 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENCLEXTA venetoclax 100 mg film-coated tablet blister pack.
Abbvie Pty Ltd - Lubricant, eye (283395)

12 December 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
SKYRIZI (Abbvie Pty Ltd)

15 July 2019

Prescription medicine registration

Active ingredients: risankizumab.
NORVIR Ritonavir 600mg/7.5mL oral liquid bottle Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Abbvie Pty Ltd
BELKYRA deoxycholic acid 10 mg/mL injection glass vial (233201)

21 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BELKYRA deoxycholic acid 10 mg/mL injection glass vial.
Abbvie Pty Ltd - Skin marking transfer paper (277150)

29 June 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Skin marking transfer paper.
Abbvie Pty Ltd- Syringe, hypodermic, metered-delivery Cancelled under Section 41GL(d) of the Act

17 April 2019

Cancellation by sponsor

Requested by Abbvie Pty Ltd
Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, reusable Cancelled under Section 41GL(d) of the Act

17 April 2019

Cancellation by sponsor

Requested by Abbvie Pty Ltd
Abbvie Pty Ltd- Applicator, antiseptic Cancelled under Section 41GL(d) of the Act

17 April 2019

Cancellation by sponsor

Requested by Abbvie Pty Ltd
LUCRIN leuprorelin acetate 5mg/mL injection multidose vial Cancelled under Section 30(1)(c) of the Act

17 April 2019

Cancellation by sponsor

Requested by Abbvie Pty Ltd

Pages

First page
Previous page
…
Page 13
Page 14
Page 15
Page 16
Current page 17
Page 18
Page 19
Page 20
Page 21
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.